bpc-157 systemic effects Examples of successful administration mechanisms for the delivery of BPC-157 & The Gut-Brain Axis:
Description
In 2023, several popular peptides BPC-157 prominent among them were placed in Category 2 after the FDA flagged safety concerns including immunogenicity risk, lack of GMP-grade API supply, and minimal human clinical data
What's included
SIRT1/PGC-1 signaling promotes mitochondrial functional recovery and reduces apoptosis after intracerebral hemorrhage in rats
42 Another RCT studied cyano-B12, 1500 g three times per day for 2 weeks (route not reported), in patients with seasonal affective disorder and found no improvements in either the B12 or the placebo group
